New combo therapy aims to improve leukemia treatment
Disease control
Ongoing
This early-phase study tests adding an experimental drug (ADI-PEG 20) to two standard leukemia medicines (venetoclax and azacitidine) for adults with acute myeloid leukemia (AML). About 38 participants, including those whose cancer returned or who are newly diagnosed with high-ri…
Phase: PHASE1 • Sponsor: Polaris Group • Aim: Disease control
Last updated May 15, 2026 11:53 UTC